Literature DB >> 2778158

Subtracted synthetic images in Gd-DTPA enhanced MR.

Y Suto1, B E Caner, Y Tamagawa, T Matsuda, I Kimura, H Kimura, T Toyama, Y Ishii.   

Abstract

The evaluation of Gd-DTPA contrast enhancement (CE) in high intensity tissues on T1-weighted magnetic resonance images, such as fat and bone marrow, is quite difficult. In this study, we used subtraction and subtracted color images in an attempt to show more clearly the Gd-DTPA CE. In addition, we also carried out sequential post-Gd-DTPA imaging to assess the changes in enhancement of lesions with time. Twenty patients were studied with these methods and our results are illustrated.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2778158     DOI： 10.1097/00004728-198909000-00038

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN： 0363-8715            Impact factor:   1.826


  6 in total

Review 1.  Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.

Authors:  Benjamin M Ellingson; Martin Bendszus; Jerrold Boxerman; Daniel Barboriak; Bradley J Erickson; Marion Smits; Sarah J Nelson; Elizabeth Gerstner; Brian Alexander; Gregory Goldmacher; Wolfgang Wick; Michael Vogelbaum; Michael Weller; Evanthia Galanis; Jayashree Kalpathy-Cramer; Lalitha Shankar; Paula Jacobs; Whitney B Pope; Dewen Yang; Caroline Chung; Michael V Knopp; Soonme Cha; Martin J van den Bent; Susan Chang; W K Al Yung; Timothy F Cloughesy; Patrick Y Wen; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2015-08-05       Impact factor: 12.300

2.  Emerging techniques and technologies in brain tumor imaging.

Authors:  Benjamin M Ellingson; Martin Bendszus; A Gregory Sorensen; Whitney B Pope
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

3.  Quantitative contrast ratio comparison between T1 (TSE at 1.5T, FLAIR at 3T), magnetization prepared rapid gradient echo and subtraction imaging at 1.5T and 3T.

Authors:  Richard Keith Downs; Mariah Haider Bashir; Chin Kau Ng; Jens Olaf Heidenreich
Journal:  Quant Imaging Med Surg       Date:  2013-06

4.  Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.

Authors:  Benjamin M Ellingson; Lauren E Abrey; Sarah J Nelson; Timothy J Kaufmann; Josep Garcia; Olivier Chinot; Frank Saran; Ryo Nishikawa; Roger Henriksson; Warren P Mason; Wolfgang Wick; Nicholas Butowski; Keith L Ligon; Elizabeth R Gerstner; Howard Colman; John de Groot; Susan Chang; Ingo Mellinghoff; Robert J Young; Brian M Alexander; Rivka Colen; Jennie W Taylor; Isabel Arrillaga-Romany; Arnav Mehta; Raymond Y Huang; Whitney B Pope; David Reardon; Tracy Batchelor; Michael Prados; Evanthia Galanis; Patrick Y Wen; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

5.  Osteoid osteoma and osteoblastoma: MRI appearances and the significance of ring enhancement.

Authors:  B A Youssef; M C Haddad; A Zahrani; H S Sharif; J L Morgan; M al-Shahed; A al-Sabty; R Choudary
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

6.  Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.

Authors:  Benjamin M Ellingson; Lauren E Abrey; Josep Garcia; Olivier Chinot; Wolfgang Wick; Frank Saran; Ryo Nishikawa; Roger Henriksson; Warren P Mason; Robert J Harris; Kevin Leu; Davis C Woodworth; Arnav Mehta; Catalina Raymond; Ararat Chakhoyan; Whitney B Pope; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.